# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-127842
Filing Date
2024-11-18
Accepted
2024-11-18 12:06:05
Documents
123
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | rgen-20231231.htm iXBRL | 10-K/A | 5197541
2 | EX-23.1 | rgen-ex23_1.htm | EX-23.1 | 6782
3 | EX-31.1 | rgen-ex31_1.htm | EX-31.1 | 13125
4 | EX-31.2 | rgen-ex31_2.htm | EX-31.2 | 13116
5 | EX-32.1 | rgen-ex32_1.htm | EX-32.1 | 16664
| Complete submission text file | 0000950170-24-127842.txt |  | 26387306

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rgen-20231231.xsd | EX-101.SCH | 2874873
126 | EXTRACTED XBRL INSTANCE DOCUMENT | rgen-20231231_htm.xml | XML | 6851798

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-14656 | Film No.: 241470430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)